Shares of Moderna Inc. fell over 8% on Wednesday afternoon, paring some of the gains from Tuesday, the stock’s best trading ...

We recently published a list of 10 Firms Post Strong Gains Amid Wall Street Bloodbath. In this article, we are going to take ...

In absolute dollar amount, the Cambridge drugmaker had the biggest drop in market cap among any public Massachusetts company ...

The Covid-19 positivity rate has also seen a rise to 7.1% this past week, versus the 5.5% figure for the past four weeks.

Moderna surged as investors turned eyed potential demand for a vaccine to protect against bird flu after the US reported its ...

Moderna stock (MRNA) fell over 7% on Wednesday, forfeiting most of its gains from Tuesday's session during a volatile week for the stock seen after the first reported bird flu death in the US, which ...

Moderna stock was on track to see a weekly gain of 10% as of Wednesday following the first reported bird flu death in the US.

Moderna shares soared as investors placed bets that the pharmaceutical giant’s development of an H5N1 bird flu vaccine could ...

With COVID vaccine sales in the doldrums and a respiratory syncytial virus (RSV) vaccine market in “contraction”, Moderna CEO ...

UBS lowered the firm’s price target on Moderna (MRNA) to $96 from $108 and keeps a Buy rating on the shares as part of a broader note on the ...

Moderna/Merck partnership and its potential in personalised cancer therapies are good opportunities for long-term investors.

Meta Platforms (META) said it would let some users browse eBay listings on [Facebook Marketplace](https:// ...